Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development

by Peter Pushko, Irina Tretyakova
Published 2020-05-01

Evaluation in Nonhuman Primates of Vaccines against Ebola Virus

by Thomas W. Geisbert, Peter Pushko, Kevin Anderson, Jonathan Smith, Kelly J. Davis, Peter B. Jahrling
Published 2002-05-01

Evaluation of Protective Efficacy of Influenza Virus Like Particles Prepared from H5N1 Virus of Clade 2.2.1.2 in Chickens

by Mohamed H. El-Husseiny, Naglaa M. Hagag, Peter Pushko, Irina Tretyakova, Mahmoud M. Naguib, Abdel Satar Arafa
Published 2021-07-01

Advanced Safety and Genetic Stability in Mice of a Novel DNA-Launched Venezuelan Equine Encephalitis Virus Vaccine with Rearranged Structural Genes

by Dylan M. Johnson, Kevin J. Sokoloski, Jenny D. Jokinen, Tia L. Pfeffer, Yong-Kyu Chu, Robert S. Adcock, Donghoon Chung, Irina Tretyakova, Peter Pushko, Igor S. Lukashevich
Published 2020-03-01

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle.

by Rick A Bright, Donald M Carter, Corey J Crevar, Franklin R Toapanta, Jonathan D Steckbeck, Kelly S Cole, Niranjan M Kumar, Peter Pushko, Gale Smith, Terrence M Tumpey, Ted M Ross
Published 2008-01-01